← 產業報告目錄
Molecular-to-Manufacturing Market Size, Share & Trends Analysis Report By Type (Reagents, Equipment, Consumables, Software, Services), By Application (Pharmaceuticals, Biotechnology, Chemical Industry, Food and Beverages, Agriculture, Environmental Testing, Academic Research), By Technology, By End-user, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Chemicals & Materials出版日期 2026-03-08頁數 165報告編號 INSIGHTACE-eb95d3ab72
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Molecular-to-Manufacturing Market is expected to expand at a compound annual growth rate of 8.23% throughout the 2024–2031 forecast period.
At its core, Molecular-to-Manufacturing pertains to growingly turning to these solutions to meet contemporary demands.
The market's upward path is underpinned by growing healthcare spending, technological evolution, and the growing focus on personalized and precision-based approaches in materials and technology.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Molecular-to-Manufacturing Market Snapshot
Chapter 4. Global Molecular-to-Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Molecular-to-Manufacturing Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Molecular-to-Manufacturing Industry Trends
Chapter 5. Molecular-to-Manufacturing Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type:
5.2.1. Reagents
5.2.2. Equipment
5.2.3. Consumables
5.2.4. Software
5.2.5. Services
Chapter 6. Molecular-to-Manufacturing Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications:
6.2.1. Pharmaceuticals
6.2.2. Biotechnology
6.2.3. Chemical Industry
6.2.4. Food and Beverages
6.2.5. Agriculture
6.2.6. Environmental Testing
6.2.7. Academic Research
Chapter 7. Molecular-to-Manufacturing Market Segmentation 3: By Technology, Estimates & Trend Analysis
7.1. Market Share by Technology, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Technologys:
7.2.1. Synthetic Biology
7.2.2. Biotechnology
7.2.3. Nanotechnology
7.2.4. Chemical Engineering
7.2.5. Data Analytics
Chapter 8. Molecular-to-Manufacturing Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-Users:
8.2.1. Research Laboratories
8.2.2. Pharmaceutical Companies
8.2.3. Biotech Firms
8.2.4. Contract Research Organizations (CROs)
8.2.5. Academic and Government Institutions
Chapter 9. Molecular-to-Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Molecular-to-Manufacturing Market, Regional Snapshot 2023 & 2031
9.2. North America
9.2.1. North America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.2.3. North America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.2.4. North America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.2.5. North America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.3. Europe
9.3.1. Europe Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.3.3. Europe Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.3.4. Europe Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.3.5. Europe Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.4. Asia Pacific
9.4.1. Asia Pacific Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.4.3. Asia Pacific Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.4.4. Asia Pacific Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts By Technology, 2024-2031
9.4.5. Asia Pacific Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.5. Latin America
9.5.1. Latin America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.5.3. Latin America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.5.4. Latin America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.5.5. Latin America Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
9.6. Middle East & Africa
9.6.1. Middle East & Africa Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type, 2024-2031
9.6.3. Middle East & Africa Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
9.6.4. Middle East & Africa Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
9.6.5. Middle East & Africa Molecular-to-Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service Offerings
10.2.1.3. Financial PerTypeance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Merck & Co., Inc.
10.2.3. Johnson & Johnson
10.2.4. Novartis AG
10.2.5. Sanofi S.A.
10.2.6. Gilead Sciences, Inc.
10.2.7. Eli Lilly and Company
10.2.8. AstraZeneca PLC
10.2.9. Bristol-Myers Squibb Company
10.2.10. Biogen Inc.
10.2.11. AbbVie Inc.
10.2.12. F. Hoffmann-La Roche Ltd
10.2.13. Amgen Inc.
10.2.14. GlaxoSmithKline plc (GSK)
10.2.15. Bayer AG
10.2.16. Other Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們